Total Payments
$27,493
2024 Payments
$1,791
Companies
57
Transactions
1,013
Medicare Patients
11,513
Medicare Billing
$865,918
Payment Breakdown by Category
Food & Beverage$22,065 (80.3%)
Travel$5,165 (18.8%)
Education$262.94 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,065 | 989 | 80.3% |
| Travel and Lodging | $5,165 | 15 | 18.8% |
| Education | $262.94 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $6,817 | 69 | $0 (2022) |
| BIOTRONIK INC. | $2,207 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,767 | 97 | $0 (2024) |
| Amgen Inc. | $1,723 | 91 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,536 | 111 | $0 (2024) |
| Medtronic, Inc. | $1,303 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,097 | 68 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $927.89 | 65 | $0 (2024) |
| Boston Scientific Corporation | $802.02 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $761.07 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,791 | 89 | Novartis Pharmaceuticals Corporation ($285.36) |
| 2023 | $3,867 | 140 | Medtronic, Inc. ($992.42) |
| 2022 | $5,321 | 170 | Abbott Laboratories ($2,649) |
| 2021 | $2,994 | 154 | Janssen Pharmaceuticals, Inc ($486.46) |
| 2020 | $1,870 | 85 | BIOTRONIK INC. ($390.96) |
| 2019 | $2,749 | 107 | Cardiovascular Systems Inc. ($586.06) |
| 2018 | $3,421 | 132 | Abbott Laboratories ($906.58) |
| 2017 | $5,481 | 136 | Abbott Laboratories ($2,895) |
All Payment Transactions
1,013 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | BIOTRONIK INC. | Solia (Device), Selectra | Food and Beverage | In-kind items and services | $67.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,416 | 5,229 | $985,796 | $237,793 |
| 2022 | 29 | 3,167 | 4,881 | $1.1M | $233,160 |
| 2021 | 23 | 2,271 | 3,469 | $858,563 | $198,876 |
| 2020 | 26 | 2,659 | 3,782 | $781,339 | $196,088 |
Total Patients
11,513
Total Services
17,361
Medicare Billing
$865,918
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 180 | 450 | $149,850 | $39,601 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 475 | $167,800 | $39,455 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 511 | 521 | $108,473 | $25,855 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 181 | $90,138 | $22,816 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 159 | 371 | $82,098 | $21,212 | 25.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 108 | $52,488 | $13,113 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 94 | 96 | $34,771 | $9,156 | 26.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 19 | 158 | $18,486 | $8,371 | 45.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,082 | 1,373 | $55,511 | $7,909 | 14.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 43 | 44 | $37,654 | $6,639 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 89 | $22,278 | $5,497 | 24.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 80 | 80 | $17,280 | $4,551 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $16,174 | $4,092 | 25.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 11 | 11 | $15,180 | $3,502 | 23.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 77 | 245 | $14,700 | $3,414 | 23.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 22 | $16,632 | $3,247 | 19.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 19 | 158 | $11,850 | $3,007 | 25.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 51 | 153 | $12,852 | $2,894 | 22.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 26 | 90 | $9,450 | $2,201 | 23.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 24 | 58 | $6,438 | $1,698 | 26.4% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 23 | 79 | $5,688 | $1,399 | 24.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 24 | 37 | $4,995 | $1,323 | 26.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 30 | $4,050 | $1,067 | 26.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 12 | $5,148 | $953.54 | 18.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 44 | 45 | $3,375 | $875.70 | 25.9% |
About Dr. Venkat Pasnoori, MD
Dr. Venkat Pasnoori, MD is a Interventional Cardiology healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740236710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Venkat Pasnoori, MD has received a total of $27,493 in payments from pharmaceutical and medical device companies, with $1,791 received in 2024. These payments were reported across 1,013 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($22,065).
As a Medicare-enrolled provider, Pasnoori has provided services to 11,513 Medicare beneficiaries, totaling 17,361 services with total Medicare billing of $865,918. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Kansas City, KS
- Active Since 05/25/2006
- Last Updated 10/02/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1740236710
Products in Payments
- OMNILINK ELITE (Device) $2,380
- Omnilink Elite vascular stent system (Device) $2,361
- XARELTO (Drug) $1,767
- Repatha (Biological) $1,458
- ENTRESTO (Drug) $1,224
- ELIQUIS (Drug) $1,114
- MICRA (Device) $952.20
- MULTAQ (Drug) $932.23
- JARDIANCE (Drug) $745.74
- Peripheral Orbital Atherectomy System (Device) $616.38
- VERQUVO (Drug) $583.20
- Supera peripheral stent system (Device) $521.58
- CVX-300CVX-300P (Device) $496.14
- Kerendia (Drug) $463.61
- Asahi Fielder coronary guide wire (Device) $452.77
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $390.68
- OPSUMIT (Drug) $350.65
- LEQVIO (Drug) $312.64
- Vascepa (Drug) $290.64
- Impella (Device) $272.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Kansas City
James Grantham, Md, MD
Interventional Cardiology — Payments: $656,310
Interventional Cardiology $656,310
Dr. Matthew Bunte, Md, MD
Interventional Cardiology — Payments: $216,002
Interventional Cardiology $216,002
Kenneth Huber, Md, MD
Interventional Cardiology — Payments: $144,313
Interventional Cardiology $144,313
Adnan Chhatriwalla, Md, MD
Interventional Cardiology — Payments: $120,601
Interventional Cardiology $120,601
Eric Hockstad, Md, MD
Interventional Cardiology — Payments: $29,484
Interventional Cardiology $29,484
Bangalore Deepak, Md, MD
Interventional Cardiology — Payments: $25,434
Interventional Cardiology $25,434